AwardedSpainGoods€4,068,592
Suministro de Doxorubicina Liposomal (DOE), Ceftriaxona (DOE), Meropenem (DOE), Asociación Ipratropio (DOE) Y Salbutamol (DOE) Y Dexametasona (DOE)
- Published
- Published 23 July 2025
- Deadline
- Closed 25 August 2025
Overview
Suministro de Doxorubicina Liposomal (DOE), Ceftriaxona (DOE), Meropenem (DOE), Asociación Ipratropio (DOE) Y Salbutamol (DOE) Y Dexametasona (DOE)
Key details
- Country
- Spain
- Status
- Awarded
- Category
- Goods
- Estimated value
- €4,068,592
- Procedure
- Open
- Published
- 23 July 2025
- Deadline
- Closed
Pharmaceutical products
Award outcome
- Awarded value
- €359,927
- Award date
- 17 December 2025
- Contract period
- — → 31 December 2000
- FRESENIUS KABI ESPAÑA, S.A.
- LABORATORIO ALDO UNION, S.L.
- MEDOCHEMIE IBERIA SA SUCURSAL EN ESPAÑA
- SUN PHARMA LABORATORIOS S L
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
8 January 2026
Contract Award Notice
30 December 2025
Contract Notice
23 July 2025
Contracting authority
OSAKIDETZA - Servicio Vasco de Salud - Organización Central
Procuring entityVitoria-Gasteiz, Spain
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.